DNMT1 and hepatocellular carcinoma: PD-L1knockdown or drug interference reverses sorafenib resistance in HCC by restoring the expression of CDH1, an intercellular adhesion molecule that inhibits HCC metastasis, which is silenced by DNMT1 methylation (90).